A pilot study employing hepatic intra-arterial irinotecan injection of drug-eluting beads as salvage therapy in liver metastatic colorectal cancer patients without extrahepatic involvement: the first southern Italy experience

Girolamo Ranieri,Artor Niccoli-Asabella,Corinna Altini,Vito Fazio,Luciana Caporusso,Ilaria Marech,G. Vinciarelli,Francesco Macina,Dario de Ceglia,Margherita Fanelli,Michele Ammendola,Giuseppe Rubini,Cosmo Damiano Gadaleta

A pilot study employing hepatic intra-arterial irinotecan injection of drug-eluting beads as salvage therapy in liver metastatic colorectal cancer patients without extrahepatic involvement: the first southern Italy experience

2016

Girolamo Ranieri
Artor Niccoli-Asabella
Corinna Altini
Vito Fazio
Luciana Caporusso
Ilaria Marech
G. Vinciarelli
Francesco Macina
Dario de Ceglia
Margherita Fanelli
Michele Ammendola
Giuseppe Rubini
Cosmo Damiano Gadaleta

Background The main aim of this prospective study was to evaluate the efficacy of drug-eluting beads with irinotecan (DEBIRI) for liver metastases from colorectal cancer. Secondary aims were to evaluate survival and toxicity.

Keywords:

Drug
Prospective cohort study
Gastroenterology
Colorectal cancer
Oncology
Salvage therapy
Toxicity
Irinotecan Injection
Irinotecan
Internal medicine
Medicine
Proportional hazards model
KRAS
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations